Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging.

BACKGROUND Diastolic dysfunction is common in patients with overt hypertrophic cardiomyopathy (HCM). Steady-state cine magnetic resonance imaging (MRI) enables measurement of the diastolic function of the left ventricle (LV), and late gadolinium enhanced MRI can delineate the presence and extent of fibrosis in HCM. The purpose of this study was to determine the relationship between the extent of myocardial fibrosis demonstrated by late gadolinium-enhanced MRI and diastolic dysfunction. METHODS AND RESULTS Seventeen patients (13 men, mean age 57.7+/-9.8 years) with HCM were studied. The severity index of late gadolinium enhancement was determined by scoring the extent of enhanced tissue in 30 myocardial segments. The peak filling rate (PFR), LV ejection fraction and LV mass were determined by cine MRI. Contrast-enhanced MRI demonstrated late gadolinium enhancement in 97 of 510 segments (19%) and 13 of the 17 patients (77%). The severity index of late gadolinium enhancement demonstrated a significant negative correlation with PFR (r= -0.86, p<0.01) and with the LV ejection fraction (r= -0.59, p<0.05). No significant correlation was observed between the severity index of late gadolinium enhancement and LV mass (r=0.23, p=0.30). CONCLUSION The extent of myocardial fibrosis revealed by late gadolinium-enhanced MRI has a strong relationship to diastolic dysfunction in patients with HCM.

[1]  M. Desai,et al.  Management of hypertrophic cardiomyopathy. , 1993, Heart disease and stroke : a journal for primary care physicians.

[2]  G. Giannakoulas,et al.  Clinical significance of tissue Doppler imaging in patients with hypertrophic cardiomyopathy. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[3]  T. Kubo,et al.  Left Ventricular Remodeling of Hypertrophic Cardiomyopathy , 2006 .

[4]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[5]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[6]  T. Nishimura,et al.  Assessment of left ventricular diastolic function by gated single-photon emission tomography: comparison with Doppler echocardiography , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[8]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[9]  E. Braunwald,et al.  Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy , 2002, Circulation.

[10]  J Paul Finn,et al.  MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on left ventricular functional parameters. , 2002, Radiology.

[11]  K. Kostner,et al.  The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: A Cine MRI study , 2001, Journal of magnetic resonance imaging : JMRI.

[12]  R. Kim,et al.  Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.

[13]  R. Kim,et al.  Visualization of presence, location, and transmural extent of healed Q-wave and non–Q-wave myocardial infarction , 2001 .

[14]  B. McCrindle,et al.  Exercise capacity in children with hypertrophic cardiomyopathy and its relation to diastolic left ventricular function. , 2001, The American journal of cardiology.

[15]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[16]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[17]  R. Vasan,et al.  Defining diastolic heart failure: a call for standardized diagnostic criteria. , 2000, Circulation.

[18]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[19]  M. Condorelli,et al.  Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. , 1999, The American journal of cardiology.

[20]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[21]  W. Roberts,et al.  Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[22]  A J Tajik,et al.  Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. , 1996, Journal of the American College of Cardiology.

[23]  W. Williams,et al.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[24]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[25]  W. Roberts,et al.  Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. , 1993, The American journal of cardiology.

[26]  B. Maron,et al.  Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. , 1990, Journal of the American College of Cardiology.

[27]  W. Roberts,et al.  Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. , 1987, The American journal of cardiology.

[28]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[29]  G. Heller,et al.  Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. , 1985, Circulation.

[30]  W. Roberts,et al.  Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. , 1979, The American journal of cardiology.

[31]  T. Kubo,et al.  Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in rural community. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[32]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[33]  J. Webb,et al.  Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. , 1990, Journal of the American College of Cardiology.